Markets

Markets Overview Market Context

Briefs Calendar

Research

News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Market Context Briefs Calendar News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive Account

Home News ArchiveVeracyte to present six genomic test studies at ESMO 2026

Live News EQUITY FLASH L impact Oct 19, 2026, 12:00 PM UTC

Veracyte to present six genomic test studies at ESMO 2026

The studies will cover breast, prostate and bladder cancer.

SquawkNews Desk

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

VCYT

Related stories

Dell Shares Rise 6% to $489.17 on Wednesday Dell shares rose 6% to $489.17, putting them on pace for their largest daily percentage gain since Sept. 11. The report credits positive comments about Dell following developments M impact | EQUITY | Oct 21, 2026, 05:57 PM UTC eBay Plans to Cut About 9% of Workforce, Eliminating 1,000 Jobs eBay announced plans to reduce its workforce by approximately 9%, or about 1,000 jobs, according to an internal memo viewed by Reuters. The move is its second major round of layoff M impact | EQUITY | Oct 21, 2026, 05:55 PM UTC Allianz Global Investors Acquires 1% Stake in HD Fire Protect Allianz Global Investors GmbH acquired the stake through open-market transactions on October 21. M impact | EQUITY | Oct 21, 2026, 05:54 PM UTC Teck Receives Strike Notice at Highland Valley Copper Operation Teck Resources said it received strike notice from United Steelworkers Local 7619 at its Highland Valley Copper operations in British Columbia. M impact | EQUITY | Oct 21, 2026, 05:54 PM UTC BlackRock CEO Warns Data-Center Delays Could Weaken Growth Larry Fink says delays in building data centers could keep computing costs elevated, add to inflation pressure and weaken economic growth. M impact | EQUITY | Oct 21, 2026, 05:53 PM UTC Novo Nordisk CagriSema Trial Shows 25% Weight Loss in Women Phase 3 results for investigational CagriSema showed an average 25% body-weight decrease after 68 weeks in more than 2,300 overweight or obese women. M impact | EQUITY | Oct 21, 2026, 05:53 PM UTC

SQUAWK/NEWS

Independent financial newsroom. Editorial expertise and proprietary AI. Paid LiveCast brings live headlines, chart context and priority audio to your trading day. Free research tools remain available.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

News & Research

Open LiveCast
Session Briefs
Market Context
Macro
Politics
Prediction Markets
News Archive

Markets & Tools

Charts & News
Markets Overview
US Stocks
Market Movers
Economic Calendar
Policy Calendar
AI Market Assistant
News Search
Instrument Directory

Guides

Charts & News Guide
How LiveCast Works
What Is an Audio Squawk?
Why News Moves Markets
News for Traders
How to Trade the News

Plans & API

Plans & Pricing
Institutional API
RSS Feed

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

© 2026 SquawkNews

Privacy Policy Terms of Use

SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.